The University of California, San Francisco (UCSF) was awarded a $474,043 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) to conduct research on the utilization, outcomes, and complications associated with third-line treatments for refractory overactive bladder (OAB) in older and frail older adults. The study aims to better understand how factors such as age, frailty, race, socioeconomic status, and provider experience impact the use and effectiveness of treatments like onabotulinumtoxinA, peripheral tibial nerve stimulation, and sacral neuromodulation in this vulnerable patient population. The goal is to develop an individualized prognostic tool to help guide treatment decision-making and improve outcomes for older and frail adults suffering from refractory OAB. The grant award period runs from September 15, 2023 through August 31, 2024.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $474.0k | 9/11/23 |